Research Article
A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers
Table 1
Demographics and clinical characteristics of patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Only lipoproteins and metabolites with significant or marginally significant differences mentioned in the table. CDR: clinical dementia rating, ADAS: Alzheimer’s disease assessment scale, CSF: cerebrospinal fluid. |